Skip to main content
. 2020 Oct 30;22(Suppl 1):iv1–iv96. doi: 10.1093/neuonc/noaa200

Table 13.

Five-Year Total, Annual Average Totala, and Average Annual Age-Adjusted Incidence Ratesb with 95% Confidence Intervals for Brain and Other Central Nervous System Tumors by Major Histology Grouping, Histology, Hispanic Ethnicityc, and Race, CBTRUS Statistical Report: U.S. Cancer Statistics – NPCR and SEER, 2013-2017

Histology All Hispanic White Hispanic Black Hispanic All Non-Hispanic
5 year total Annual average Rate 95% CI 5 year total Annual average Rate 95% CI 5 year total Annual average Rate 95% CI 5 year total Annual average Rate 95% CI
Tumors of Neuroepithelial Tissue 11,766 2,353 5.01 4.92-5.11 10,815 2,163 5.10 5.00-5.20 291 58 2.60 2.27-2.97 101,233 20,247 6.85 6.81-6.89
Pilocytic Astrocytoma 812 162 0.24 0.23-0.26 732 146 0.25 0.23-0.27 22 4 0.12 0.07-0.19 4,345 869 0.38 0.37-0.40
Diffuse Astrocytoma 816 163 0.33 0.30-0.35 751 150 0.33 0.31-0.36 17 3 0.12 0.06-0.20 6,606 1,321 0.48 0.47-0.49
Anaplastic Astrocytoma 665 133 0.28 0.26-0.30 611 122 0.28 0.26-0.31 21 4 0.17 0.10-0.27 6,447 1,289 0.45 0.44-0.46
Unique Astrocytoma Variants 189 38 0.07 0.06-0.08 173 35 0.07 0.06-0.08 -- -- -- -- 934 187 0.07 0.07-0.08
Malignant 113 23 0.04 0.03-0.05 106 21 0.04 0.04-0.05 -- -- -- -- 656 131 0.05 0.05-0.05
Non-Malignant 76 15 0.02 0.02-0.03 67 13 0.02 0.02-0.03 -- -- -- -- 278 56 0.02 0.02-0.03
Glioblastoma 4,723 945 2.46 2.39-2.53 4,414 883 2.51 2.44-2.59 118 24 1.41 1.15-1.71 55,322 11,064 3.32 3.29-3.35
Oligodendroglioma 429 86 0.16 0.15-0.18 395 79 0.17 0.15-0.19 -- -- -- -- 3,265 653 0.25 0.24-0.26
Anaplastic Oligodendroglioma 235 47 0.10 0.08-0.11 214 43 0.10 0.08-0.11 -- -- -- -- 1,624 325 0.12 0.11-0.12
Oligoastrocytic Tumors 170 34 0.07 0.06-0.08 158 32 0.07 0.06-0.08 -- -- -- -- 1,401 280 0.11 0.10-0.11
Ependymal Tumors 962 192 0.36 0.34-0.39 868 174 0.36 0.34-0.39 20 4 0.15 0.08-0.24 5,876 1,175 0.44 0.42-0.45
Malignant 624 125 0.23 0.21-0.25 570 114 0.23 0.21-0.25 -- -- -- -- 3,346 669 0.25 0.24-0.26
Non-Malignant 338 68 0.13 0.12-0.15 298 60 0.13 0.12-0.15 -- -- -- -- 2,530 506 0.18 0.18-0.19
Glioma Malignant, NOS 1,042 208 0.40 0.37-0.42 934 187 0.40 0.37-0.43 38 8 0.29 0.19-0.42 7,047 1,409 0.54 0.53-0.55
Choroid Plexus Tumors 164 33 0.05 0.04-0.06 152 30 0.05 0.05-0.06 -- -- -- -- 662 132 0.05 0.05-0.06
Malignant 26 5 0.01 0.00-0.01 24 5 0.01 0.00-0.01 -- -- -- -- 102 20 0.01 0.01-0.01
Non-Malignant 138 28 0.05 0.04-0.05 128 26 0.05 0.04-0.06 -- -- -- -- 560 112 0.05 0.04-0.05
Other Neuroepithelial Tumors 21 4 0.01 0.00-0.01 17 3 0.01 0.00-0.01 -- -- -- -- 86 17 0.01 0.01-0.01
Malignant -- -- -- -- -- -- -- -- -- -- -- -- 52 10 0.00 0.00-0.01
Non-Malignant -- -- -- -- -- -- -- -- -- -- -- -- 34 7 0.00 0.00-0.00
Neuronal and Mixed Neuronal Glial Tumors 677 135 0.23 0.21-0.24 605 121 0.23 0.21-0.24 16 3 0.08 0.05-0.14 4,250 850 0.34 0.33-0.35
Malignant 123 25 0.05 0.04-0.06 110 22 0.05 0.04-0.06 -- -- -- -- 823 165 0.06 0.05-0.06
Non-Malignant 554 111 0.18 0.16-0.19 495 99 0.18 0.16-0.20 -- -- -- -- 3,427 685 0.28 0.27-0.29
Tumors of the Pineal Region 116 23 0.04 0.03-0.05 107 21 0.04 0.03-0.05 -- -- -- -- 670 134 0.05 0.05-0.06
Malignant 76 15 0.03 0.02-0.03 70 14 0.03 0.02-0.03 -- -- -- -- 370 74 0.03 0.03-0.03
Non-Malignant 40 8 0.02 0.01-0.02 37 7 0.02 0.01-0.02 -- -- -- -- 300 60 0.02 0.02-0.03
Embryonal Tumors 745 149 0.22 0.21-0.24 684 137 0.23 0.21-0.25 -- -- -- -- 2,698 540 0.24 0.23-0.25
Tumors of Cranial and Spinal Nerves 3,193 639 1.41 1.36-1.46 2,873 575 1.40 1.35-1.45 81 16 0.72 0.56-0.91 32,378 6,476 2.14 2.11-2.16
Nerve Sheath Tumors 3,187 637 1.41 1.36-1.46 2,867 573 1.40 1.34-1.45 81 16 0.72 0.56-0.91 32,344 6,469 2.13 2.11-2.16
Malignant 43 9 0.02 0.01-0.03 37 7 0.02 0.01-0.03 -- -- -- -- 180 36 0.01 0.01-0.01
Non-Malignant 3,144 629 1.39 1.34-1.44 2,830 566 1.38 1.33-1.43 81 16 0.72 0.56-0.91 32,164 6,433 2.12 2.10-2.15
Other Tumors of Cranial and Spinal Nerves -- -- -- -- -- -- -- -- -- -- -- -- 34 7 0.00 0.00-0.00
Tumors of Meninges 15,869 3,174 8.44 8.30-8.58 14,496 2,899 8.43 8.28-8.57 457 91 5.62 5.07-6.20 147,677 29,535 9.21 9.16-9.26
Meningioma 15,254 3,051 8.20 8.06-8.34 13,927 2,785 8.18 8.04-8.32 450 90 5.57 5.02-6.15 143,716 28,743 8.93 8.88-8.98
Malignant 187 37 0.09 0.08-0.11 173 35 0.10 0.08-0.11 -- -- -- -- 1,563 313 0.10 0.09-0.10
Non-Malignant 15,067 3,013 8.10 7.97-8.24 13,754 2,751 8.08 7.94-8.22 443 89 5.48 4.94-6.05 142,153 28,431 8.83 8.79-8.88
Mesenchymal Tumors 211 42 0.08 0.07-0.10 198 40 0.09 0.08-0.10 -- -- -- -- 1,250 250 0.09 0.09-0.10
Primary Melanocytic Lesions -- -- -- -- -- -- -- -- -- -- -- -- 98 20 0.01 0.01-0.01
Other Neoplasms Related to the Meninges 394 79 0.16 0.14-0.17 362 72 0.16 0.14-0.18 -- -- -- -- 2,613 523 0.18 0.18-0.19
Lymphoma and Hematopoietic Neoplasms 956 191 0.50 0.47-0.53 896 179 0.51 0.48-0.55 18 4 0.17 0.09-0.27 7,192 1,438 0.44 0.43-0.45
Lymphoma 924 185 0.49 0.45-0.52 868 174 0.50 0.47-0.54 18 4 0.17 0.09-0.27 6,993 1,399 0.43 0.42-0.44
Other Hematopoietic Neoplasms 32 6 0.01 0.01-0.02 28 6 0.01 0.01-0.02 -- -- -- -- 199 40 0.01 0.01-0.02
Germ Cell Tumors and Cysts 347 69 0.11 0.10-0.12 314 63 0.11 0.10-0.12 -- -- -- -- 1,237 247 0.11 0.10-0.11
Germ Cell Tumors, Cysts and Heterotopias 347 69 0.11 0.10-0.12 314 63 0.11 0.10-0.12 -- -- -- -- 1,237 247 0.11 0.10-0.11
Malignant 251 50 0.07 0.07-0.08 226 45 0.08 0.07-0.09 -- -- -- -- 843 169 0.07 0.07-0.08
Non-Malignant 96 19 0.03 0.03-0.04 88 18 0.03 0.03-0.04 -- -- -- -- 394 79 0.03 0.03-0.04
Tumors of Sellar Region 11,655 2,331 4.86 4.77-4.95 10,443 2,089 4.82 4.72-4.91 400 80 3.54 3.17-3.94 61,618 12,324 4.32 4.29-4.36
Tumors of the Pituitary 11,184 2,237 4.68 4.59-4.77 10,011 2,002 4.64 4.54-4.73 386 77 3.45 3.08-3.85 58,960 11,792 4.13 4.09-4.16
Malignant 25 5 0.01 0.01-0.02 21 4 0.01 0.01-0.02 -- -- -- -- 117 23 0.01 0.01-0.01
Non-Malignant 11,159 2,232 4.67 4.58-4.76 9,990 1,998 4.63 4.53-4.72 386 77 3.45 3.08-3.85 58,843 11,769 4.12 4.08-4.15
Craniopharyngioma 471 94 0.18 0.16-0.19 432 86 0.18 0.16-0.20 -- -- -- -- 2,658 532 0.20 0.19-0.21
Unclassified Tumors 2,394 479 1.15 1.10-1.20 2,187 437 1.16 1.11-1.22 63 13 0.65 0.48-0.86 17,658 3,532 1.16 1.15-1.18
Hemangioma 850 170 0.35 0.33-0.38 782 156 0.36 0.33-0.39 21 4 0.16 0.09-0.26 4,876 975 0.35 0.34-0.36
Neoplasm Unspecified 1,524 305 0.79 0.75-0.83 1,389 278 0.79 0.75-0.84 42 8 0.49 0.34-0.69 12,608 2,522 0.81 0.79-0.82
Malignant 600 120 0.35 0.32-0.38 555 111 0.35 0.32-0.38 -- -- -- -- 5,987 1,197 0.36 0.36-0.37
Non-Malignant 924 185 0.44 0.41-0.47 834 167 0.44 0.41-0.47 -- -- -- -- 6,621 1,324 0.44 0.43-0.45
All Other 20 4 0.01 0.01-0.02 16 3 0.01 0.01-0.02 -- -- -- -- 174 35 0.01 0.01-0.01
TOTAL d 46,180 9,236 21.48 21.27-21.69 42,024 8,405 21.53 21.31-21.75 1,321 264 13.36 12.57-14.18 368,993 73,799 24.23 24.15-24.31
Malignant 12,782 2,556 5.70 5.60-5.81 11,795 2,359 5.81 5.70-5.93 308 62 2.83 2.48-3.21 110,653 22,131 7.33 7.29-7.37
Non-Malignant 33,398 6,680 15.78 15.60-15.96 30,229 6,046 15.72 15.53-15.90 1,013 203 10.54 9.83-11.28 258,340 51,668 16.90 16.84-16.97

a. Annual average cases are calculated by dividing the five year total by five.

b. Rates are per 100,000 and are age-adjusted to the 2000 US standard population.

c. Hispanic ethnicity is not mutually exclusive of race; Classified using the North American Association of Central Cancer Registries Hispanic Identification Algorithm, version 2 (NHIA v2).

d. Refers to all brain tumors including histologies not presented in this table.

- Counts and rates are not presented when fewer than 20 cases were reported for the specific category. The suppressed cases are included in the counts and rates for totals.

Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; NPCR, National Program of Cancer Registries; SEER, Surveillance, Epidemiology, and End Results Program; CI, confidence interval; NOS, not otherwise specified